http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010109358-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2008-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2010109358-A
titleOfInvention SOLID MEDICINAL FORMS WITH CONTROLLED DELIVERY CONTAINING AZITROMYCIN
abstract 1. A solid controlled release dosage form for oral administration comprising azithromycin in an amount of less than 250 mg. ! 2. A controlled release solid dosage form for oral administration according to claim 1, characterized in that said dosage form is a tablet. ! 3. A solid controlled release dosage form for oral administration according to claim 1, characterized in that said dosage form is a capsule. ! 4. A controlled release oral dosage form according to claim 1, characterized in that the amount of azithromycin is 200 mg or less. ! 5. A controlled release oral dosage form according to claim 4, characterized in that said amount of azithromycin is 150 mg or less. ! 6. A controlled release solid dosage form for oral administration according to claim 5, characterized in that said amount of azithromycin is 100 mg or less. ! 7. A controlled release oral dosage form according to claim 6, characterized in that said amount of azithromycin is 80 mg or less. ! 8. The solid controlled release dosage form for oral administration according to claim 1, characterized in that the dosage form is coated with an enteric coating. ! 9. A controlled-release solid dosage form for oral administration according to claim 8, characterized in that the enteric coating comprises a methacrylic copolymer. ! 10. Solid dosage form with counter
priorityDate 2007-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441

Total number of triples: 24.